1-10 of 10
John P. Klein, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Recipient HLA-C1 Enhances The Clinical Advantage Of Killer-Cell Immunoglobulin-Like Receptor B haplotype Donors In Myeloablative Unrelated Transplantation For Acute Myelogenous Leukemia

Sarah Cooley, MD, Daniel J. Weisdorf, MD, Lisbeth A Guethlein, John P Klein, PhD, Tao Wang, PhD, Steve G.E. Marsh, Stephen Spellman, MBS, Michael D Haagenson, MS, Koy Saeturn, Martha Ladner, Elizabeth Trachtenberg, Peter Parham, Jeffrey S. Miller, MD
Journal: Blood
Blood (2013) 122 (21): 549.
https://doi.org/10.1182/blood.V122.21.549.549
Published: 2013
Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Mary E. D. Flowers, MD, John P. Klein, PhD, Michael T. Hemmer, MS, Peigang Li, MS, Corey S. Cutler, MD, Alvaro Urbano-Ispizua, MD, Daniel R. Couriel, MD, Robert Peter Gale, MD, PhD, DSc, FACP, Yoshihiro Inamoto, MD, PhD, Joseph H. Antin, MD, Brian J. Bolwell, MD, Michael Boyiadzis, MD, MHSc, Jean-Yves Cahn, MD, Mitchell S. Cairo, MD, Luis M. Isola, MD, David A. Jacobsohn, MD, Madan Jagasia, MBBS, MS, Thomas R. Klumpp, MD, Effie W. Petersdorf, MD, Stella Santarone, MD, Harry C. Schouten, MD, PhD, John R. Wingard, MD, PhD, Stephen Spellman, MBS, Daniel J. Weisdorf, MD, Steven Z. Pavletic, MD, Stephanie J. Lee, MD, MPH, Mary M. Horowitz, MD, MS, Mukta Arora, MD, MS
Journal: Blood
Blood (2013) 122 (21): 706.
https://doi.org/10.1182/blood.V122.21.706.706
Published: 2013
Journal Articles

Significant Improvement In Day 100 and 1-Year Overall Survival In Patients Who Underwent Myeloablative Allogeneic Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005

Theresa Hahn, PhD, Philip L. McCarthy, MD, Anna Hassebroek, MPH, John P. Klein, PhD, J. Douglas Rizzo, MD, MS, Susan Parsons, MD, MRP, Steven Joffe, MD, MPH, Navneet S. Majhail, MD, MS
Journal: Blood
Blood (2010) 116 (21): 3509.
https://doi.org/10.1182/blood.V116.21.3509.3509
Published: 2010
Journal Articles

Allogeneic Hematopoietic Cell Transplantation Can Cure Some Patients with Acute Leukemia in Relapse or Primary Induction Failure: A CIBMTR Study.

Michel Duval, MD, Wensheng He, MS, John P. Klein, PhD, Martin S. Tallman, MD, John F. DiPersio, MD, PhD, Donald W. Bunjes, MD, PhD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2009) 114 (22): 528.
https://doi.org/10.1182/blood.V114.22.528.528
Published: 2009
Journal Articles

Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML.

Sarah Cooley, Lisbeth Guethlein, PhD, Elizabeth Trachtenberg, PhD, Martha Ladner, Xianghua Luo, Chap T Le, Tao Wang, PhD, John P. Klein, PhD, Steven G.E. Marsh, PhD, Stephen Spellman, Michael D Haagenson, MS, Daniel J. Weisdorf, MD, Peter Parham, Jeffrey S. Miller
Journal: Blood
Blood (2009) 114 (22): 665.
https://doi.org/10.1182/blood.V114.22.665.665
Published: 2009
Journal Articles

Long-Term Survival and Late Relapse in 5-Year Survivors of Allogeneic Hematopoietic-Cell Transplantation (HCT) for Chronic Myeloid Leukemia (CML) in First Chronic Phase.

John M. Goldman, DM, FRCP, FRCPath, Navneet S. Majhail, MD, MS, John P. Klein, PhD, Zhiwei Wang, MS, Kathleen A. Sobocinski, MS, Mukta Arora, MD, Mary M. Horowitz, MD, MS, J. Douglas Rizzo, MD, MS
Journal: Blood
Blood (2009) 114 (22): 3321.
https://doi.org/10.1182/blood.V114.22.3321.3321
Published: 2009
Journal Articles

Decreased Infections in Recipients of Unrelated Donor (URD Hematopoietic Cell Transplantation (HCT) from Donors with An Activating KIR B Genotype (B/x)

Marcie Tomblyn, MD, MS, Jo-Anne Young, MD, Michael D Haagenson, MS, John P. Klein, PhD, Jan Storek, MD, PhD, Stephen Spellman, Sarah Cooley, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2008) 112 (11): 351.
https://doi.org/10.1182/blood.V112.11.351.351
Published: 2008
Journal Articles

High Resolution HLA Matched Unrelated Donor Versus HLA Identical Sibling Transplantation for Chronic Phase CML.

Mukta Arora, MD, MS, Stephen Spellman, MBS, Michael Haagenson, MS, John P. Klein, PhD, Carolyn Hurley, PhD, George Selby, MD, Joseph Antin, MD, Nancy Kernan, MD, Craig Kollman, PhD, Auayporn Nademanee, MD, Daniel J. Weisdorf, MD, Mary M. Horowitz, MD, MS, Philip McGlave, MD, Effie Petersdorf, MD
Journal: Blood
Blood (2007) 110 (11): 171.
https://doi.org/10.1182/blood.V110.11.171.171
Published: 2007
Journal Articles

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

K. Scott Baker, MD, MS, Anna Hassebroek, MPH, Karen Ballen, MD, Carolyn Bigelow, MD, Haydar Frangoul, MD, Cheryl Hardy, PhD, Stephanie Lee, MD,MPH, Galen Switzer, PhD, J. Douglas Rizzo, MD, John P. Klein, PhD, Navneet Majhail, MD,MS, Stella Davies, MB.BS,PhD
Journal: Blood
Blood (2007) 110 (11): 3064.
https://doi.org/10.1182/blood.V110.11.3064.3064
Published: 2007
Journal Articles

Matched Pairs Analysis of IV vs. PO Busulfan as a Conditioning Agent Prior to Transplantation.

Kathleen A. Sobocinski, MS, Peter F. Thall, PhD, B. Nebiyou Bekele, PhD, John P. Klein, PhD, Shari Lennon, Mary M. Horowitz, MS, MD, Borje Andersson, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 349.
https://doi.org/10.1182/blood.V104.11.349.349
Published: 2004